[Breast Cancer: Targets and Therapy] In this report, the researchers review the treatment of triple-negative breast cancer and specifically shed light on advances in immunotherapy and newly approved drugs for this challenging-to-manage disease.
Women largely do not know breast density ups risk for breast cancer even in U.S. states with notification.
Few differences seen between women residing in states that require notifications and those who do not.
False-negative rate lower for age-adjusted deep learning risk score versus density-based models.
Rates of mortality for invasive second breast cancer higher in those with prior radiotherapy for DCIS.